10x Genomics (MEX:TXG) FCF Margin % : 11.71% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is 10x Genomics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 10x Genomics's Free Cash Flow for the three months ended in Sep. 2024 was MXN350 Mil. 10x Genomics's Revenue for the three months ended in Sep. 2024 was MXN2,986 Mil. Therefore, 10x Genomics's FCF Margin % for the quarter that ended in Sep. 2024 was 11.71%.

As of today, 10x Genomics's current FCF Yield % is 1.25%.

The historical rank and industry rank for 10x Genomics's FCF Margin % or its related term are showing as below:

MEX:TXG' s FCF Margin % Range Over the Past 10 Years
Min: -85.76 Med: -25.01 Max: 4.3
Current: 4.3

During the past 7 years, the highest FCF Margin % of 10x Genomics was 4.30%. The lowest was -85.76%. And the median was -25.01%.

MEX:TXG's FCF Margin % is ranked better than
56.24% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 2.3 vs MEX:TXG: 4.30

10x Genomics FCF Margin % Historical Data

The historical data trend for 10x Genomics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics FCF Margin % Chart

10x Genomics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-3.31

-85.76

-25.01

-32.00

-10.46

10x Genomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-26.52	12.13	-13.22	2.36	11.71

Competitive Comparison of 10x Genomics's FCF Margin %

For the Health Information Services subindustry, 10x Genomics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10x Genomics's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where 10x Genomics's FCF Margin % falls into.

10x Genomics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

10x Genomics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1098.591	/	10502.426
	=	-10.46 %

10x Genomics's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	349.542	/	2986.113
	=	11.71 %

10x Genomics FCF Margin % Related Terms

Thank you for viewing the detailed overview of 10x Genomics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

10x Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (MEX:TXG) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

TXG:USA 0A88:UK 1KJ:Germany

Address

6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588

Website

https://www.10xgenomics.com

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.